Published in Leukemia on August 01, 1993
Phase II study of methotrexate, vincristine, pegylated-asparaginase, and dexamethasone (MOpAD) in patients with relapsed/refractory acute lymphoblastic leukemia. Am J Hematol (2014) 0.79
The Relationship Between Risk Factors and Survival in Adult Acute Lymphoblastic Leukemia. Iran J Cancer Prev (2016) 0.75
High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: analysis of 270 patients treated between 1985 and 1993. J Clin Oncol (1999) 10.86
Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remission. N Engl J Med (1998) 5.98
Service profiling and outcomes benchmarking using the CORE-OM: toward practice-based evidence in the psychological therapies. Clinical Outcomes in Routine Evaluation-Outcome Measures. J Consult Clin Psychol (2001) 2.72
Effects of single-dose interleukin-12 exposure on interleukin-12-associated toxicity and interferon-gamma production. Blood (1997) 2.66
Acute megakaryocytic leukemia: the Eastern Cooperative Oncology Group experience. Blood (2000) 2.65
Fluorouracil and recombinant alfa-2a-interferon: an active regimen against advanced colorectal carcinoma. J Clin Oncol (1989) 2.36
Extramedullary acute promyelocytic leukemia. Cancer (1996) 2.31
Obesity among Navajo adolescents. Relationship to dietary intake and blood pressure. Am J Dis Child (1992) 2.30
Neuroimaging and obesity: current knowledge and future directions. Obes Rev (2011) 2.23
PHF6 mutations in adult acute myeloid leukemia. Leukemia (2010) 2.20
Torsades de pointes in 3 patients with leukemia treated with arsenic trioxide. Blood (2001) 2.20
Phase I study of recombinant human CD40 ligand in cancer patients. J Clin Oncol (2001) 2.12
Methods to detect P-glycoprotein-associated multidrug resistance in patients' tumors: consensus recommendations. Cancer Res (1996) 1.82
Efficient detection of hereditary nonpolyposis colorectal cancer gene carriers by screening for tumor microsatellite instability before germline genetic testing. Gastroenterology (2001) 1.78
Colonic ischemia complicating immunotherapy with interleukin-2 and interferon-alpha. Cancer (1991) 1.77
Phase I clinical and pharmacokinetic study of taxol. Cancer Res (1987) 1.74
Treatment of acute myelocytic leukemia: a study by cancer and leukemia group B. Blood (1981) 1.68
Lytic and turbid plaque-type mutants of lymphocytic choriomeningitis virus as a cause of neurological disease or persistent infection. Infect Immun (1971) 1.56
Percutaneous pericardial catheter drainage in childhood. Am J Cardiol (1992) 1.45
Phase I trial of taxol given as a 24-hour infusion every 21 days: responses observed in metastatic melanoma. J Clin Oncol (1987) 1.44
Evolving immunosuppressive microenvironment during human cervical carcinogenesis. Mucosal Immunol (2008) 1.44
Fuel and vehicle technology choices for passenger vehicles in achieving stringent CO2 targets: connections between transportation and other energy sectors. Environ Sci Technol (2009) 1.39
Managing climate risk. Science (2001) 1.37
Long-term survival in acute myeloid leukemia: the Eastern Cooperative Oncology Group experience. Cancer (1997) 1.36
Minichromosome maintenance protein 2 expression in prostate: characterization and association with outcome after therapy for cancer. Clin Cancer Res (2001) 1.34
Cytoreductive surgery for stage IV renal cell carcinoma. J Urol (1995) 1.33
Taxol produces a predominantly sensory neuropathy. Neurology (1989) 1.32
Natural history of Alström syndrome in early childhood: onset with dilated cardiomyopathy. J Pediatr (1996) 1.32
Balloon aortic valvuloplasty: results of the Valvuloplasty and Angioplasty of Congenital Anomalies Registry. Am J Cardiol (1990) 1.29
Thromboembolic complications after fontan procedures--the role of prophylactic anticoagulation. J Thorac Cardiovasc Surg (1998) 1.24
Neuroblastoma. Effect of genetic factors on prognosis and treatment. Cancer (1992) 1.23
Guidelines for cardiac monitoring of children during and after anthracycline therapy: report of the Cardiology Committee of the Childrens Cancer Study Group. Pediatrics (1992) 1.22
Rapid migration of 111indium-labeled granulocytes to sites of infection. N Engl J Med (1981) 1.22
Interleukin-2 and lymphokine-activated killer cell therapy of solid tumors: analysis of toxicity and management guidelines. J Clin Oncol (1989) 1.19
Evaluation of ultrasound-based prostate localization for image-guided radiotherapy. Int J Radiat Oncol Biol Phys (2003) 1.18
Interleukin-2 therapy in patients with metastatic malignant melanoma: a phase II study. J Clin Oncol (1990) 1.17
Hyperleukocytosis in adult acute nonlymphocytic leukemia: impact on remission rate and duration, and survival. J Clin Oncol (1987) 1.17
Antibody formation in persistent tolerant infection with lymphocytic choriomeningitis virus. Nature (1969) 1.16
Randomized phase III trial of treatment with high-dose interleukin-2 either alone or in combination with interferon alfa-2a in patients with advanced melanoma. J Clin Oncol (1993) 1.16
Myelodysplastic and myeloproliferative disorders of childhood: a study of 167 patients. Blood (1999) 1.14
Randomized phase II trial of high-dose interleukin-2 either alone or in combination with interferon alfa-2b in advanced renal cell carcinoma. J Clin Oncol (1993) 1.14
Capping the cost of compliance with the Kyoto Protocol and recycling revenues into land-use projects. ScientificWorldJournal (2001) 1.11
Specific food intolerance: its place as a cause of gastrointestinal symptoms. Gut (1985) 1.11
Silver-Russell patients showing a broad range of ICR1 and ICR2 hypomethylation in different tissues. Clin Genet (2010) 1.10
The Fontan procedure: analysis of cohorts and late complications. Cardiol Young (2000) 1.09
Chemotherapy versus chemoimmunotherapy (CAF v CAFVP v CMF each +/- MER) for metastatic carcinoma of the breast: a CALGB study. Cancer and Leukemia Group B. J Clin Oncol (1987) 1.08
The significance of pretreatment CD4 count on the outcome and treatment tolerance of HIV-positive patients with anal cancer. Int J Radiat Oncol Biol Phys (1999) 1.07
Chemical dependency allegations and the Minnesota Board of Medical Practice. Minn Med (1993) 1.07
Cyclosporine A neurotoxicity in a patient with idiopathic renal magnesium wasting. Pediatr Neurol (2000) 1.07
The detection of neutralizing antibody to lymphocytic choriomeningitis virus in mice. J Immunol (1969) 1.06
Effects of all-trans retinoic acid or chemotherapy on the molecular regulation of systemic blood coagulation and fibrinolysis in patients with acute promyelocytic leukemia. J Thromb Haemost (2004) 1.06
An additional mitochondrial tRNA(Ile) point mutation (A-to-G at nucleotide 4295) causing hypertrophic cardiomyopathy. Hum Mutat (1996) 1.05
A phase II study of taxol in patients with malignant melanoma. Invest New Drugs (1991) 1.04
Treatment of refractory and relapsed acute myelogenous leukemia with combination chemotherapy plus the multidrug resistance modulator PSC 833 (Valspodar). Blood (1999) 1.03
Ambulatory blood pressure monitoring and left ventricular mass and function after successful surgical repair of coarctation of the aorta. J Am Coll Cardiol (1992) 1.03
Prealbumin in Swedish patients with senile systemic amyloidosis and familial amyloidotic polyneuropathy. Scand J Immunol (1985) 1.03
Hyperparathyroidism presenting as the first lesion in multiple endocrine neoplasia type 1. Am J Med (1987) 1.03
Interaction of fluorouracil and interferon in human colon cancer cell lines: cytotoxic and cytokinetic effects. Cancer Res (1990) 1.03
Maternally inherited hypertrophic cardiomyopathy due to a novel T-to-C transition at nucleotide 9997 in the mitochondrial tRNA(glycine) gene. Am J Hum Genet (1994) 1.03
Association of thyroid disease with acute leukemia. Am J Hematol (1992) 1.03
Balloon angioplasty of recurrent coarctation: a 12-year review. J Am Coll Cardiol (1997) 1.02
Transcatheter device closure of atrial septal defects in the elderly: technical considerations and short-term outcomes. Int J Cardiol (2006) 1.02
Noncompaction of the myocardium associated with Roifman syndrome. Cardiol Young (2001) 1.01
Symptomatic atrial arrhythmias and transcatheter closure of atrial septal defects in adult patients. Heart (2004) 1.01
A standardized meal stimulation test of the endocrine pancreas for early detection of pancreatic endocrine tumors in multiple endocrine neoplasia type 1 syndrome: five years experience. J Clin Endocrinol Metab (1987) 1.01
Percutaneous treatment of hydatid cysts under sonographic guidance. Dig Dis Sci (1994) 1.01
Regulation of the uptake and degradation of beta-very low density lipoprotein in human monocyte macrophages. J Biol Chem (1983) 1.00
Complete disruption of the main pancreatic duct: endoscopic management. Gastrointest Endosc (1995) 0.99
Combination chemotherapy with mastectomy or radiotherapy for stage III breast carcinoma: a Cancer and Leukemia Group B study. J Clin Oncol (1988) 0.99
Pulsed Doppler assessment of pulmonary vein obstruction. Am Heart J (1985) 0.99
Preliminary evaluation of prostate cancer metastatic risk biomarkers. Int J Biol Markers (2005) 0.98
Effects of dietary cholesterol and fat saturation on plasma lipoproteins in an ethnically diverse population of healthy young men. J Clin Invest (1995) 0.98
Nosocomial infections in neutropenic cancer patients. Infect Control Hosp Epidemiol (1993) 0.98
Fluorometric analysis of transferable membrane pores. Biochemistry (1985) 0.97
Fenestration of the Fontan circuit as treatment for plastic bronchitis. Pediatr Cardiol (2005) 0.97
Role of defective monocyte interleukin-10 release in tumor necrosis factor-alpha overproduction in alcoholics cirrhosis. Hepatology (1995) 0.97
Transcatheter closure of atrial septal defects using the Cardio-Seal implant. Heart (2000) 0.97
Positron emission tomography. The technique and its applications to the study of the cardiovascular system. Cardiol Clin (1983) 0.96
Improved freedom from PSA failure with whole pelvic irradiation for high-risk prostate cancer. Int J Radiat Oncol Biol Phys (1998) 0.95
Bupivacaine use after knee arthroscopy: pharmacokinetics and pain control study. Arthroscopy (1990) 0.95
Successful percutaneous treatment of anomalous left coronary artery from pulmonary artery. Int J Cardiol (2007) 0.94
Dose of radiation received by the bulb of the penis correlates with risk of impotence after three-dimensional conformal radiotherapy for prostate cancer. Urology (2001) 0.94
Alloimmunization following platelet transfusion: the absence of a dose-response relationship. Blood (1981) 0.94
Enhanced antitumor efficacy of a herpes simplex virus mutant isolated by genetic selection in cancer cells. Proc Natl Acad Sci U S A (2001) 0.94
Age of onset evidence for anticipation in familial non-Hodgkin's lymphoma. Br J Haematol (2000) 0.94
Case report: clinical findings and successful resection of melanoma metastatic to the right atrium. Cancer Invest (1994) 0.94
Cis-Dichlorodiammine platinum and adriamycin therapy for advanced gynecological and genitourinary neoplasms. Cancer (1980) 0.94
Noninvasive recognition of functional pulmonary atresia by echocardiography. Am J Cardiol (1984) 0.93
Magnetic resonance imaging in primary amyloidosis. Acta Radiol (1987) 0.93
Mycophenolate mofetil in pediatric heart transplant recipients: a single-center experience. Pediatr Transplant (2001) 0.93
Foreign compound metabolism studies with human liver obtained as surgical waste. Relation to donor characteristics and effects of tissue storage. Drug Metab Dispos (1988) 0.92
Increased circulating colony-stimulating factor-1 in patients with preleukemia, leukemia, and lymphoid malignancies. Blood (1991) 0.92